Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis

Abstract

The formation of anti-infliximab Abs during treatment with infliximab is associated with a loss of clinical response, the appearance of infusion reactions and discontinuation of treatment.